Projects per year
Fingerprint Dive into the research topics where NAmur MEdicine & Drug Innovation Center is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Thromboxanes
Medicine & Life Sciences
Thromboxane Receptors
Medicine & Life Sciences
Thromboxane A2
Medicine & Life Sciences
Anticoagulants
Medicine & Life Sciences
Molecular dynamics
Chemical Compounds
Derivatives
Chemical Compounds
Molecules
Chemical Compounds
Blood Platelets
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Lütfiye Alpan
- Department of Pharmacy
- Namur Nanosafety Center
- Namur Research Institute for Life Sciences
- Namur Thrombosis and Hemostasis Center
- NAmur MEdicine & Drug Innovation Center
Person: Volunteer staff, ATO Staff, Definitive ATO Staff
Marie-Ange Angladon
- Faculty of Sciences
- NAmur MEdicine & Drug Innovation Center
- Namur Research Institute for Life Sciences
- Euraxess
Person: Scientific Staff FRIA Scholar, Doctorate in Sciences, Definitive ATO Staff
Projects 2006 2022
Cancer immunotherapy and dual IDO/TDO inhibitors: design, synthesis, physico-chemical and biological characterizations
1/10/19 → 30/09/21
Project: Research
Development of new compounds targeting coagulation factor XIIa using innovative microfluidic assays in the context of fragment-based drug discovery
Davoine, C., Pochet, L. & Fillet, M.
1/10/18 → 30/09/20
Project: Research
Research Output 1987 2019
Andexanet alfa for the reversal of factor Xa inhibitors
Favresse, J., Hardy, M., van Dievoet, M. A., Sennesael, A. L., Douxfils, J., Samama, C. M., Vornicu, O., Dincq, A. S., Lessire, S. & Mullier, F., 4 May 2019, In : Expert Opinion on Biological Therapy. 19, 5, p. 387-397 11 p.Research output: Contribution to journal › Article
Pharmacodynamics
Hemorrhage
Phase III Clinical Trials
Factor Xa
Pharmacokinetics
An ultra-high-performance liquid chromatography coupled with a tandem mass spectrometry method for the quantification of edoxaban: The importance to measure active metabolite
Siriez, R., Evrard, J., Laloy, J., Dogne, J-M. & Douxfils, J., 2019.Research output: Contribution to conference › Poster
File
An updated meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia
Haguet, H., Mullier, F., Graux, C., Dogne, J-M. & Douxfils, J., 13 Jun 2019.Research output: Contribution to conference › Poster
Activities 1987 2019
Adèle Laurent
Laurence Leherte (Host)7 Oct 2019 → 9 Oct 2019
Activity: Hosting a visitor types › Hosting a researcher
Neha Tripathi
Laurence Leherte (Host)7 Oct 2019 → 9 Oct 2019
Activity: Hosting a visitor types › Hosting a researcher
The Journal of Physical Chemistry C (Journal)
Laurence Leherte (Peer reviewer)9 Oct 2019
Activity: Publication peer-review and editorial work types › Publication peer-review
Prizes
3rd Runner-up at the "Why Medicinal Chemistry" competition
Charlotte Bouckaert (Recipient), 16 Sep 2015
Prize: Prize (including medals and awards)
55th ASH Annual Meeting and Exposition - Abstract Achievement Award
Jonathan Douxfils (Recipient), 7 Dec 2013
Prize: Prize (including medals and awards)
56th ASH Annual Meeting and Exposition - Abstract Achievement Award
Jonathan Douxfils (Recipient), 6 Dec 2014
Prize: Prize (including medals and awards)
Press / Media
Les Éclaireurs: Hématologie, Marionette & Bioluminescence
14/07/18
1 Media contribution
Press/Media: Research
Researchers analyse the toxicity of nanomaterials
21/02/18
1 Media contribution
Press/Media: Expert Comment
Datasets
CCDC 918730: Experimental Crystal Structure Determination
Leyssens, T. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2013
DOI: 10.5517/cczv0g8, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cczv0g8&sid=DataCite
Dataset
CCDC 813564: Experimental Crystal Structure Determination
Frederick, R. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2012
DOI: 10.5517/ccw9l0r, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccw9l0r&sid=DataCite
Dataset
CCDC 918411: Experimental Crystal Structure Determination
Leyssens, T. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2013
DOI: 10.5517/ccztp5m, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccztp5m&sid=DataCite
Dataset
Student theses
Analytical and clinical validation of sensitive assays for the diagnosis of immune heparin-induced thrombocytopenia
Author: Minet, V., 2017Supervisor: Dogne, J. (Supervisor), Mullier, F. (External person) (Co-Supervisor), Laloy, J. (Jury), Lucas, S. (Jury), Masereel, B. (Jury), Chatelain, M. (External person) (Jury), Hoylaerts, M. F. (External person) (Jury) & Tardy, B. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
Conception, synthèse, caractérisation, évaluation pharmacologique et études in vivo de dérivés de l'harmine en tant que nouvelles molécules aux propriétés anticancéreuses.
Author: Meinguet, C., 25 Sep 2015Supervisor: Wouters, J. (Supervisor), Vercauteren, D. (President), Masereel, B. (Jury), Lanners, S. (Jury), Willand, N. (External person) (Jury) & Mathieu, V. (External person) (Jury)
Student thesis: Doc types › Doctor of Sciences
File
Conception de composés anti-cancéreux ciblant le domaine PWWP des DNMT3A et DNMT3B
Author: Themans, Q., 2014Supervisor: Wouters, J. (Supervisor)
Student thesis: Master types › Master in Chemistry